{
  "id": "9992342630696fdb57f8bc9ee5c7b0ba0a8e8fd8",
  "title": "WHO issues global guideline on the use of GLP-1 medicines in treating obesity",
  "summary": "To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.",
  "canonicalUrl": "https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity",
  "source": {
    "id": "who_news",
    "name": "World Health Organization - News (EN)",
    "url": "https://www.who.int/news",
    "feedUrl": "https://www.who.int/rss-feeds/news-english.xml",
    "country": "UN",
    "language": "en"
  },
  "publishedAt": "2025-12-01T13:00:25.000Z",
  "fetchedAt": "2025-12-24T00:05:45.493Z",
  "category": "health",
  "tags": [],
  "image": null,
  "language": "en",
  "storagePath": "data/articles/health/2025/12/01/9992342630696fdb57f8bc9ee5c7b0ba0a8e8fd8.json"
}
